购物车
- 全部删除
- 您的购物车当前为空
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 396 | 现货 | |
5 mg | ¥ 1,150 | 现货 | |
10 mg | ¥ 1,570 | 现货 | |
25 mg | ¥ 2,830 | 现货 | |
50 mg | ¥ 4,250 | 现货 | |
100 mg | ¥ 6,280 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 987 | 现货 |
产品描述 | CBL0137 hydrochloride (Curaxin-137 hydrochloride) activates p53 and inhibits NF-kB (EC50: 0.37/0.47 μM) in the cell-based p53 and NF-kB reporter assays, respectively. It also suppresses histone chaperone FACT. |
靶点活性 | NF-κB:0.47 μM(EC50), p53:0.37 μM(EC50), FACT: |
体外活性 | 在胰腺癌细胞系中,CBL0137是诱导凋亡的有效剂。它不仅对多种肿瘤细胞的增殖有毒性,也对胰腺癌干细胞有效。CBL0137能激活p53并抑制由HSF-1和NF-κB介导的细胞应激途径。CBL0137能与DNA结合,但不会对DNA造成任何化学修饰。然而,CBL0137与DNA的结合导致促进染色质转录(Facilitates Chromatin Transcription, FACT)复合体的功能失活。在CBL0137处理的细胞中,FACT从核质中丢失并被困在染色质中,导致包括NF-kB介导的转录在内的FACT依赖性转录受到抑制。此外,染色质中FACT的陷阱还会导致酪蛋白激酶2(CK2)-依赖的磷酸化和p53的激活。 |
体内活性 | 在小鼠中,CBL0137对包括患者源性异种移植物和耐双氮芥的PANC-1型胰腺导管腺癌(PDA)模型表现出强大的抑制作用。CBL0137根据其提出的作用机制针对胶质母细胞瘤(GBM)并能穿透血脑屏障,对TMZ敏感和抗感的原位模型均有效。该化合物能穿越血脑屏障的特性,尤其是通过静脉(i.v)给药时,预示着其治疗中枢神经系统(CNS)肿瘤的潜力。在原位模型中,静脉给药相比口服能更多地使化合物武积聚于肿瘤组织,从而提高了生物可利用度。 |
激酶实验 | MiaPaca2 and BxPC-3 cells are treated with CBL0137 hydrochloride for 4 or 24 h. Cells are harvested in 1× Cell Culture Lysis Reagent containing protease and phosphatase inhibitors. Lysates 5 to 20 μg are separated on SDS-PAGE gels and transferred to PVDF membranes. Blots are probed with antibodies specific for SSRP1, SPT16, RRM1, and RRM2. |
细胞实验 | Effects of CBLC137 (2 μM for 24 hours) on cell cycle in tumor (HT1080, RCC45, MiaPaca) and normal cells (Wi38, NKE-hTERT) are examined using FACS analysis of propidium iodide-stained cells. |
动物实验 | Animal Models: xenograft mouse models of cancer. Formulation: water. Dosages: 30 mg/kg. Administration: p.o. |
别名 | CBL0137, CBLC137, Curaxin 137, CBL-C137 hydrochloride, Curaxin-137 hydrochloride |
分子量 | 372.88 |
分子式 | C21H25ClN2O2 |
CAS No. | 1197397-89-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 25 mg/mL (67.05 mM), Sonication is recommended. DMSO: 36 mg/mL (96.5 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O/DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.